These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 354677)

  • 1. Metronidazole (flagyl) and misonidazole (Ro-07-0582): reduction by facultative anaerobes and cytotoxic action on hypoxic bacteria and mammalian cells in vivo.
    Basag SH; Dunlop JR; Searle AJ; Willson RL
    Br J Cancer Suppl; 1978 Jun; 3():132-5. PubMed ID: 354677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Toxic and radiosensitizing effect of reduced nitroimidazoles on E. coli B/r cells].
    Riabchenko NI; Semin IuA; Petrova KM; Kutmin AI
    Radiobiologiia; 1983; 23(4):505-9. PubMed ID: 6351162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metronidazole (Flagyl), misonidazole (Ro 07-0582), iron, zinc and sulphur compounds in cancer therapy.
    Bahnemann D; Basaga H; Dunlop JR; Searle AJ; Willson RL
    Br J Cancer Suppl; 1978 Jun; 3():16-9. PubMed ID: 277218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ["In vitro" susceptibility of some aerobic and anaerobic bacteria to three 5-nitro-imidazole derivatives: metronidazole, ornidazole and tinidazole (author's transl)].
    Dublanchet A; Durieux R
    Ann Microbiol (Paris); 1980; 131(1):45-59. PubMed ID: 7362180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity of metronidazole (Flagyl) and misonidazole (Ro-07-0582): enhancement by lactate.
    Mahood JS; Willson RL
    Br J Cancer; 1981 Mar; 43(3):350-4. PubMed ID: 7225286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electron affinic sensitization. V. Radiosensitization of hypoxic bacteria and mammalian cells in vitro by some nitroimidazoles and nitropyrazoles.
    Asquith JC; Watts ME; Patel K; Smithen CE; Adams GE
    Radiat Res; 1974 Oct; 60(1):108-18. PubMed ID: 10881704
    [No Abstract]   [Full Text] [Related]  

  • 7. Activation of radiosensitizers by hypoxic cells.
    Olive PL; Durand RE
    Br J Cancer Suppl; 1978 Jun; 3():124-8. PubMed ID: 354676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Action of clinically utilized 5-nitroimidazoles on microorganisms.
    Müller M
    Scand J Infect Dis Suppl; 1981; 26():31-41. PubMed ID: 6941454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanism of binding of the radiosensitizers metronidazole and misonidazole (Ro-07-0582) to bovine and human serum albumin--a proton NMR study.
    Sułkowska A; Lubas B; Wilczok T
    Radiat Res; 1981 Jan; 85(1):1-12. PubMed ID: 7465767
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro susceptibility of anaerobic bacteria to nitroimidazoles.
    Olsson-Liljequist B; Nord CE
    Scand J Infect Dis Suppl; 1981; 26():42-5. PubMed ID: 6941455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mode of action of metronidazole on anaerobic bacteria and protozoa.
    Müller M
    Surgery; 1983 Jan; 93(1 Pt 2):165-71. PubMed ID: 6849201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of misonidazole on formation of thymine damage by gamma rays.
    Remsen JF
    Radiat Res; 1985 Feb; 101(2):306-11. PubMed ID: 3975359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between metabolic reduction rates and electron affinity of nitroheterocycles.
    Olive PL
    Cancer Res; 1979 Nov; 39(11):4512-5. PubMed ID: 387217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology and toxicology of sensitizers: mechanism studies.
    Rauth AM
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1293-300. PubMed ID: 6469753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of nitroheterocyclic compounds by mammalian tissues in vivo.
    Yeung TC; Sudlow G; Koch RL; Goldman P
    Biochem Pharmacol; 1983 Jul; 32(14):2249-53. PubMed ID: 6870947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fast kinetics study of the modes of action of some different radiosensitizers in bacteria.
    Michael BD; Harrop HA; Maughan RL; Patel KB
    Br J Cancer Suppl; 1978 Jun; 3():29-33. PubMed ID: 354678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitroimidazoles: in vitro activity and efficacy in anaerobic infections.
    Tally FP; Goldin B; Sullivan NE
    Scand J Infect Dis Suppl; 1981; 26():46-53. PubMed ID: 6941456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic properties of hydroxylamino- and amino-misonidazole, possible metabolic products of misonidazole, in hypoxic HeLa S3 cells.
    Murayama C; Hori H; Mori T; Inayama S
    Gan; 1983 Oct; 74(5):693-8. PubMed ID: 6642142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitrichomonad action, mutagenicity, and reduction of metronidazole and other nitroimidazoles.
    Lindmark DG; Müller M
    Antimicrob Agents Chemother; 1976 Sep; 10(3):476-82. PubMed ID: 791102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of excision repair on the mutagenesis of misonidazole.
    Kacinski BM; Mroczkowski Z; Rupp WD
    Cancer Clin Trials; 1980; 3(1):69-71. PubMed ID: 6993036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.